Perkenalan

Halaman ini memberikan analisis komprehensif tentang riwayat insider trading yang diketahui di Lisa D Earnhardt. Insider adalah pejabat, direktur, atau investor penting dalam suatu perusahaan. Adalah ilegal bagi insider untuk melakukan perdagangan di perusahaan mereka berdasarkan informasi spesifik dan non-publik. Hal ini tidak berarti bahwa mereka dilarang melakukan perdagangan apa pun di perusahaan mereka sendiri. Namun, mereka harus melaporkan semua perdagangan ke SEC melalui Formulir 4. Meskipun ada pembatasan ini, penelitian akademis menunjukkan bahwa insider – secara umum – cenderung mengungguli pasar di perusahaan mereka sendiri.

Profitabilitas Perdagangan Rata-rata

Profitabilitas perdagangan rata-rata adalah pengembalian rata-rata dari seluruh pembelian pasar terbuka yang dilakukan oleh insider dalam 3 tahun terakhir. Untuk menghitungnya, kami memeriksa setiap pembelian pasar terbuka dan tidak terencana yang dilakukan oleh insider, tidak termasuk semua perdagangan yang ditandai sebagai bagian dari rencana perdagangan 10b5-1. Kami kemudian menghitung kinerja rata-rata perdagangan tersebut selama 3, 6, dan 12 bulan, merata-ratakan setiap durasi tersebut untuk menghasilkan metrik kinerja akhir untuk setiap perdagangan. Terakhir, kami menghitung rata-rata semua metrik kinerja untuk menghitung metrik kinerja bagi insider. Daftar ini hanya mencakup insider yang telah melakukan setidaknya tiga perdagangan dalam 2 tahun terakhir.

Jika profitabilitas perdagangan insider ini adalah "T/A", maka insider tersebut belum melakukan pembelian di pasar terbuka dalam 3 tahun terakhir, atau perdagangan yang mereka lakukan terlalu baru untuk menghitung metrik kinerja yang dapat diandalkan.

Frekuensi Pembaruan: Harian

Lihat daftar insider trader yang paling menguntungkan.

Perusahaan dengan Posisi Insider yang Dilaporkan

Pengajuan SEC menunjukkan Lisa D Earnhardt telah melaporkan kepemilikan atau perdagangan di perusahaan berikut:

Keamanan Judul Kepemilikan Terbaru yang Dilaporkan
US:ABT / Abbott Laboratories EVP AND GROUP PRESIDENT 90.407
US:XENT / Intersect ENT Inc Director 48.333
US:NVRO / Nevro Corp. Director 5.303
US:KNSY / Kensey Nash Corp Director 0
Bagaimana Menafsirkan Grafik

Bagan berikut menunjukkan kinerja saham sekuritas setelah setiap perdagangan pasar terbuka dan tidak terencana yang dilakukan oleh Lisa D Earnhardt. Perdagangan yang tidak direncanakan adalah perdagangan yang tidak dilakukan sebagai bagian dari rencana perdagangan 10b5-1. Kinerja saham dipetakan sebagai persentase perubahan kumulatif harga saham. Misalnya, jika perdagangan insider dilakukan pada tanggal 1 Januari 2019, grafik akan menunjukkan persentase perubahan harian sekuritas hingga hari ini. Jika harga saham naik dari $10 menjadi $15 selama waktu ini, persentase perubahan harga saham kumulatif akan menjadi 50%. Perubahan harga dari $10 menjadi $20 adalah 100%, dan perubahan harga dari $10 menjadi $5 adalah -50%.

Pada akhirnya, kami mencoba untuk menentukan seberapa dekat korelasi perdagangan insider dengan keuntungan berlebih (positif atau negatif) pada harga saham untuk melihat apakah insider mengatur waktu perdagangannya untuk mendapatkan keuntungan dari informasi insider. Pertimbangkan situasi di mana insider melakukan hal ini. Dalam situasi ini, kita mengharapkan (a) keuntungan positif setelah pembelian, atau (b) keuntungan negatif setelah penjualan. Dalam kasus (a), grafik PEMBELIAN akan menunjukkan serangkaian kurva yang miring ke atas, yang menunjukkan keuntungan positif setelah setiap transaksi pembelian. Dalam kasus (b), grafik PENJUALAN akan menunjukkan serangkaian kurva yang miring ke bawah, yang menunjukkan keuntungan negatif setelah setiap transaksi penjualan.

Namun, hal ini saja tidak cukup untuk menarik kesimpulan. Jika, misalnya, harga saham perusahaan berada dalam kenaikan non-siklus selama bertahun-tahun, maka kita perkirakan semua lahan pasca pembelian akan miring ke atas. Demikian pula, penurunan non-siklus selama bertahun-tahun akan mengakibatkan penurunan pasca-perdagangan. Tak satu pun dari grafik ini menunjukkan aktivitas insider trading.

Indikator terkuat adalah situasi di mana harga saham sangat bersiklus, dan terdapat sinyal positif pada grafik PEMBELIAN dan plot negatif pada grafik PENJUALAN. Situasi ini akan sangat memberi isyarat kepada insider yang mengatur waktu perdagangan demi keuntungan finansial mereka.

Riwayat Insider Trading

Tabel ini menunjukkan daftar lengkap perdagangan insider yang dilakukan oleh Lisa D Earnhardt sebagaimana diungkapkan kepada Securities Exchange Commission (SEC).

Tanggal Berkas Tanggal Trans Formulir Kode Keamanan Kode 10b5-1 Saham Sisa Saham Persen
Mengubah
Saham
Harga
Trans
Nilai
Tersisa
Nilai
2026-03-03 2026-02-27 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -8.577 90.407 -8,67 116,26 -997.162 10.510.718
2026-02-26 2026-02-24 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 27.056 98.984 37,62
2025-03-07 2025-03-07 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -200 71.928 -0,28 136,64 -27.329 9.828.602
2025-03-07 2025-03-07 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 200 72.128 0,28 80,98 16.196 5.840.925
2025-03-07 2025-03-06 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -91.167 71.928 -55,90 133,82 -12.199.968 9.625.405
2025-03-07 2025-03-06 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 91.167 163.095 126,75 80,98 7.382.704 13.207.433
2025-03-04 2025-02-28 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -8.322 71.928 -10,37 135,87 -1.130.710 9.772.857
2025-02-27 2025-02-25 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 18.788 80.250 30,57
2024-05-08 2024-05-07 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -22.852 61.462 -27,10 106,25 -2.428.119 6.530.589
2024-03-04 2024-03-01 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -694 84.314 -0,82 118,50 -82.239 9.991.209
2024-03-04 2024-02-29 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -7.669 85.008 -8,27 120,05 -920.663 10.205.210
2024-02-23 2024-02-21 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 17.240 92.677 22,85
2023-03-02 2023-03-01 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -943 75.437 -1,23 100,70 -94.960 7.596.506
2023-03-02 2023-02-28 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -7.631 76.380 -9,08 99,77 -761.345 7.620.433
2023-02-22 2023-02-17 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 15.855 84.011 23,26
2022-06-14 2022-06-10 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -19.592 68.156 -22,33 112,71 -2.208.214 7.681.863
2022-06-14 2022-06-10 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -2.882 87.748 -3,18 112,71 -324.830 9.890.077
2022-03-02 2022-03-01 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -943 90.630 -1,03 118,15 -111.416 10.707.962
2022-03-02 2022-02-28 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -5.168 91.573 -5,34 122,41 -632.615 11.209.451
2022-02-23 2022-02-18 4 ABT ABBOTT LABORATORIES
Option (right to buy)
A - Award 80.380 80.380
2022-02-23 2022-02-18 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 17.247 96.741 21,70
2021-06-11 2021-06-10 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -2.881 79.494 -3,50 109,05 -314.173 8.668.821
2021-03-02 2021-03-01 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -943 82.375 -1,13 120,61 -113.735 9.935.249
2021-03-02 2021-02-26 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -2.621 83.318 -3,05 121,58 -318.661 10.129.802
2021-02-23 2021-02-19 4 ABT ABBOTT LABORATORIES
Option (right to buy)
A - Award 71.070 71.070
2021-02-23 2021-02-19 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 13.865 85.939 19,24
2020-06-12 2020-06-10 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -872 72.074 -1,20 90,84 -79.216 6.547.490
2020-06-12 2020-06-10 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -2.855 72.946 -3,77 90,27 -257.721 6.584.835
2020-02-25 2020-02-21 4 ABT ABBOTT LABORATORIES
Option (right to buy)
A - Award 114.940 114.940
2020-02-25 2020-02-21 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 18.855 75.801 33,11
2019-07-26 2019-07-24 4 XENT Intersect ENT, Inc.
Stock Option (Right to buy)
A - Award 48.333 48.333
2019-07-26 2019-07-24 4 XENT Intersect ENT, Inc.
Stock Option (Right to buy)
D - Sale to Issuer -48.333 0 -100,00
2019-07-26 2019-07-24 4 XENT Intersect ENT, Inc.
Stock Option (Right to buy)
A - Award 45.500 45.500
2019-07-26 2019-07-24 4 XENT Intersect ENT, Inc.
Stock Option (Right to buy)
D - Sale to Issuer -45.500 0 -100,00
2019-07-26 2019-07-24 4 XENT Intersect ENT, Inc.
Stock Option (Right to buy)
A - Award 196.875 196.875
2019-07-26 2019-07-24 4 XENT Intersect ENT, Inc.
Stock Option (Right to buy)
D - Sale to Issuer -196.875 0 -100,00
2019-07-26 2019-07-24 4 XENT Intersect ENT, Inc.
Stock Option (Right to buy)
A - Award 150.000 150.000
2019-07-26 2019-07-24 4 XENT Intersect ENT, Inc.
Stock Option (Right to buy)
D - Sale to Issuer -150.000 0 -100,00
2019-07-26 2019-07-24 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
A - Award 19.688 19.688
2019-07-26 2019-07-24 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
D - Sale to Issuer -19.688 0 -100,00
2019-07-26 2019-07-24 4 XENT Intersect ENT, Inc.
Stock Option (Right to buy)
A - Award 44.625 44.625
2019-07-26 2019-07-24 4 XENT Intersect ENT, Inc.
Stock Option (Right to buy)
D - Sale to Issuer -44.625 0 -100,00
2019-06-12 2019-06-10 4 ABT ABBOTT LABORATORIES
Option (right to buy)
A - Award 91.367 91.367
2019-06-12 2019-06-10 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 39.515 56.946 226,69
2019-06-12 2019-06-10 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 17.431 17.431
2019-06-12 3 ABT ABBOTT LABORATORIES
Common shares without par value
0
2019-05-17 2019-05-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -9.500 140.000 -6,35
2019-05-17 2019-05-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -9.500 421.983 -2,20 25,59 -243.102 10.798.418
2019-05-17 2019-05-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 9.500 431.483 2,25 13,05 123.975 5.630.853
2019-04-17 2019-04-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -6.016 48.333 -11,07
2019-04-17 2019-04-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -7.500 149.500 -4,78
2019-04-17 2019-04-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -29.588 421.983 -6,55 28,43 -841.243 11.997.778
2019-04-17 2019-04-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 6.016 451.571 1,35 1,20 7.219 541.885
2019-04-17 2019-04-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 7.500 445.555 1,71 13,05 97.875 5.814.493
2019-01-18 2019-01-16 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
A - Award 157.500 157.500
2019-01-18 2019-01-16 4 XENT Intersect ENT, Inc.
Common Stock
A - Award 33.800 438.055 8,36
2019-01-03 2019-01-01 4 XENT Intersect ENT, Inc.
Common Stock
F - Taxes -10.428 404.255 -2,51 26,57 -277.046 10.740.045
2018-12-26 2018-12-20 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -35.000 54.349 -39,17
2018-12-26 2018-12-20 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 35.000 414.683 9,22 1,20 42.000 497.620
2018-12-19 2018-12-17 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -5.000 157.000 -3,09
2018-12-19 2018-12-17 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -20.000 379.683 -5,00 29,73 -594.504 11.286.153
2018-12-19 2018-12-17 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 5.000 399.683 1,27 13,05 65.250 5.215.863
2018-11-19 2018-11-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -5.000 162.000 -2,99
2018-11-19 2018-11-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -20.000 394.683 -4,82 30,01 -600.296 11.846.331
2018-11-19 2018-11-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 5.000 414.683 1,22 13,05 65.250 5.411.613
2018-10-17 2018-10-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -5.000 167.000 -2,91
2018-10-17 2018-10-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -20.000 409.683 -4,65 29,63 -592.614 12.139.194
2018-10-17 2018-10-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 5.000 429.683 1,18 13,05 65.250 5.607.363
2018-09-19 2018-09-17 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -5.000 172.000 -2,82
2018-09-19 2018-09-17 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -20.000 424.683 -4,50 29,14 -582.862 12.376.579
2018-09-19 2018-09-17 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 5.000 444.683 1,14 13,05 65.250 5.803.113
2018-08-17 2018-08-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -5.000 177.000 -2,75
2018-08-17 2018-08-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -20.000 439.683 -4,35 26,51 -530.194 11.655.864
2018-08-17 2018-08-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 5.000 459.683 1,10 13,05 65.250 5.998.863
2018-07-18 2018-07-16 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -5.000 182.000 -2,67
2018-07-18 2018-07-16 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -20.000 454.683 -4,21 33,08 -661.686 15.042.869
2018-07-18 2018-07-16 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 5.000 474.683 1,06 13,05 65.250 6.194.613
2018-06-19 2018-06-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -5.000 187.000 -2,60
2018-06-19 2018-06-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -20.000 469.683 -4,08 36,79 -735.710 17.277.524
2018-06-19 2018-06-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 5.000 489.683 1,03 13,05 65.250 6.390.363
2018-05-23 2018-05-21 4 NVRO NEVRO CORP
Common Stock
A - Award 3.785 5.303 249,34
2018-05-17 2018-05-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -15.000 192.000 -7,25
2018-05-17 2018-05-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -15.000 484.683 -3,00 39,22 -588.244 19.007.474
2018-05-17 2018-05-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 15.000 499.683 3,09 13,05 195.750 6.520.863
2018-04-17 2018-04-16 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -15.000 207.000 -6,76
2018-04-17 2018-04-16 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -15.000 484.683 -3,00 39,59 -593.918 19.190.781
2018-04-17 2018-04-16 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 15.000 499.683 3,09 13,05 195.750 6.520.863
2018-03-16 2018-03-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -15.000 222.000 -6,33
2018-03-16 2018-03-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -15.000 484.683 -3,00 38,32 -574.791 18.572.762
2018-03-16 2018-03-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 15.000 499.683 3,09 13,05 195.750 6.520.863
2018-02-16 2018-02-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -15.000 237.000 -5,95
2018-02-16 2018-02-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -15.000 484.683 -3,00 36,40 -545.938 17.640.474
2018-02-16 2018-02-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 15.000 499.683 3,09 13,05 195.750 6.520.863
2018-01-19 2018-01-18 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -11.166 484.683 -2,25 33,47 -373.695 16.220.983
2018-01-19 2018-01-17 4 XENT Intersect ENT, Inc.
Stock Options (Right to buy)
A - Award 119.000 119.000
2018-01-19 2018-01-17 4 XENT Intersect ENT, Inc.
Common Stock
A - Award 25.500 495.849 5,42
2018-01-03 2018-01-01 4 XENT Intersect ENT, Inc.
Common Stock
F - Taxes -6.834 470.349 -1,43 33,93 -231.897 15.960.259
2017-12-18 2017-12-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -2.000 6.016 -24,95
2017-12-18 2017-12-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -10.685 477.183 -2,19 31,87 -340.512 15.206.963
2017-12-18 2017-12-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 2.000 487.868 0,41 1,20 2.400 585.442
2017-11-17 2017-11-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -10.000 8.016 -55,51
2017-11-17 2017-11-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -20.000 485.868 -3,95 27,88 -557.620 13.546.486
2017-11-17 2017-11-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 10.000 505.868 2,02 1,20 12.000 607.042
2017-10-17 2017-10-16 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -10.000 18.016 -35,69
2017-10-17 2017-10-16 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -20.000 495.868 -3,88 28,37 -567.336 14.066.188
2017-10-17 2017-10-16 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 10.000 515.868 1,98 1,20 12.000 619.042
2017-09-19 2017-09-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -10.000 28.016 -26,30
2017-09-19 2017-09-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -20.000 505.868 -3,80 30,19 -603.870 15.273.925
2017-09-19 2017-09-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 10.000 525.868 1,94 1,20 12.000 631.042
2017-08-17 2017-08-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -10.000 38.016 -20,83
2017-08-17 2017-08-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -20.000 515.868 -3,73 30,79 -615.810 15.883.834
2017-08-17 2017-08-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 10.000 535.868 1,90 1,20 12.000 643.042
2017-08-17 2017-08-09 4 XENT Intersect ENT, Inc.
Common Stock
G - Gift -35.000 525.868 -6,24
2017-07-18 2017-07-17 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -10.000 48.016 -17,24
2017-07-18 2017-07-17 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -20.000 560.868 -3,44 29,03 -580.642 16.283.176
2017-07-18 2017-07-17 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 10.000 580.868 1,75 1,20 12.000 697.042
2017-06-19 2017-06-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -2.625 58.016 -4,33
2017-06-19 2017-06-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -7.375 0 -100,00
2017-06-19 2017-06-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -20.000 570.868 -3,38 26,10 -521.978 14.899.027
2017-06-19 2017-06-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 7.375 590.868 1,26 1,20 8.850 709.042
2017-06-19 2017-06-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 2.625 583.493 0,45 1,20 3.150 700.192
2017-05-30 2017-05-25 4 NVRO NEVRO CORP
Stock Option (Right to Buy)
A - Award 3.545 3.545
2017-05-30 2017-05-25 4 NVRO NEVRO CORP
Common Stock
A - Award 1.518 1.518
2017-05-16 2017-05-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -10.000 7.375 -57,55
2017-05-16 2017-05-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -20.000 580.868 -3,33 22,98 -459.520 13.346.023
2017-05-16 2017-05-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 10.000 600.868 1,69 1,20 12.000 721.042
2017-04-18 2017-04-17 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -10.000 17.375 -36,53
2017-04-18 2017-04-17 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -20.000 590.868 -3,27 16,06 -321.244 9.490.640
2017-04-18 2017-04-17 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 10.000 610.868 1,66 1,20 12.000 733.042
2017-03-16 2017-03-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -10.000 27.375 -26,76
2017-03-16 2017-03-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -10.000 600.868 -1,64 15,02 -150.188 9.024.316
2017-03-16 2017-03-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -10.000 610.868 -1,61 15,03 -150.265 9.179.208
2017-03-16 2017-03-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 10.000 620.868 1,64 1,20 12.000 745.042
2017-02-17 2017-02-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -20.000 37.375 -34,86
2017-02-17 2017-02-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -20.000 610.868 -3,17 13,01 -260.170 7.946.476
2017-02-17 2017-02-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 20.000 630.868 3,27 1,20 24.000 757.042
2017-01-20 2017-01-18 4 XENT Intersect ENT, Inc.
Stock Options (Right to buy)
A - Award 252.000 252.000
2017-01-20 2017-01-18 4 XENT Intersect ENT, Inc.
Common Stock
A - Award 54.000 610.868 9,70
2016-10-19 2016-10-17 4 XENT Intersect ENT, Inc.
Stock Options (Right to buy)
M - Exercise -400 56.975 -0,70
2016-10-19 2016-10-17 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -400 556.868 -0,07 18,00 -7.200 10.023.624
2016-10-19 2016-10-17 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 400 557.268 0,07 1,20 480 668.722
2016-05-20 2016-05-18 4 NVRO NEVRO CORP
Stock Option (Right to Buy)
A - Award 3.240 3.240
2016-04-19 2016-04-18 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -4.000 57.375 -6,52
2016-04-19 2016-04-18 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -8.500 556.868 -1,50 19,50 -165.740 10.858.258
2016-04-19 2016-04-18 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 4.000 565.368 0,71 1,20 4.800 678.442
2016-04-19 2016-04-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -20.000 61.375 -24,58
2016-04-19 2016-04-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -20.000 561.368 -3,44 18,34 -366.848 10.296.836
2016-04-19 2016-04-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 20.000 581.368 3,56 1,20 24.000 697.642
2016-03-16 2016-03-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -9.000 561.368 -1,58 18,01 -162.084 10.109.845
2016-01-20 2016-01-15 4 XENT Intersect ENT, Inc.
Stock Options (Right to buy)
A - Award 225.000 225.000
2016-01-20 2016-01-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise -8.000 81.375 -8,95
2016-01-20 2016-01-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -12.500 570.368 -2,14 19,26 -240.808 10.987.911
2016-01-20 2016-01-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 8.000 582.868 1,39 1,20 9.600 699.442
2015-12-16 2015-12-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -6.820 574.868 -1,17 19,85 -135.408 11.413.717
2015-11-17 2015-11-16 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -6.818 581.688 -1,16 18,00 -122.732 10.471.082
2015-10-16 2015-10-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -6.818 588.506 -1,15 18,72 -127.619 11.015.655
2015-09-16 2015-09-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -6.818 595.324 -1,13 25,99 -177.229 15.475.031
2015-08-19 2015-08-17 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -6.818 602.142 -1,12 28,51 -194.385 17.167.369
2015-07-16 2015-07-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -19.318 608.960 -3,07 29,62 -572.153 18.035.934
2015-07-01 2015-06-29 4 NVRO NEVRO CORP
Stock Option (right to buy)
A - Award 5.853 5.853
2015-06-16 2015-06-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -19.318 628.278 -2,98 29,30 -565.992 18.407.729
2015-05-19 2015-05-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -19.318 647.596 -2,90 23,69 -457.628 15.341.031
2015-04-17 2015-04-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -19.318 666.914 -2,82 25,96 -501.544 17.314.755
2015-03-18 2015-03-16 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -19.318 686.232 -2,74 23,56 -455.057 16.164.950
2015-02-19 2015-02-17 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X -19.318 705.550 -2,67 22,69 -438.343 16.009.564
2015-01-23 2015-01-21 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
A - Award 150.000 150.000
2014-07-23 3 XENT Intersect ENT, Inc.
Common Stock
1.475.918
2014-07-23 3 XENT Intersect ENT, Inc.
Common Stock
777.232
2014-07-23 3 XENT Intersect ENT, Inc.
Common Stock
1.475.918
2014-07-23 3 XENT Intersect ENT, Inc.
Common Stock
777.232
2012-06-26 2012-06-22 4 KNSY KENSEY NASH CORP
Common Stock
D - Sale to Issuer -5.100 0 -100,00 38,50 -196.350
P
Pasar terbuka atau pembelian swasta atas sekuritas non-derivatif atau derivatif
S
Pasar terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi derivatif
D
Penjualan atau pengalihan surat berharga kembali kepada perusahaan
F
Pembayaran harga pelaksanaan atau kewajiban perpajakan dengan menggunakan sebagian surat berharga yang diterima dari perusahaan
G
Pemberian surat berharga oleh atau kepada insider
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Penggunaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Suatu transaksi dilaporkan secara sukarela pada Formulir 4
J
Lainnya (disertai catatan kaki yang menjelaskan transaksi)